Journal Article > ResearchFull Text
Infect Agent Cancer. 2018 January 19; Volume 13 (Issue 1); DOI:10.1186/s13027-018-0177-6
Fardhdiani V, Molfino L, Zamudio AG, Manuel R, Luciano G, et al.
Infect Agent Cancer. 2018 January 19; Volume 13 (Issue 1); DOI:10.1186/s13027-018-0177-6
Kaposi's sarcoma (KS) is a common HIV-associated malignancy associated with disability, pain and poor outcomes. The cornerstone of its treatment is antiretroviral therapy, but advanced disease necessitates the addition of chemotherapy. In high-income settings, this often consists of liposomal anthracyclines, but in Mozambique, the first line includes conventional doxorubicin, bleomycin and vincristine, which is poorly-tolerated. Médecins Sans Frontières supports the Ministry of Health (MOH) in a specialized HIV and KS treatment center at the Centro de Referencia de Alto Maé in Maputo.